Autoproteolytic Activation of Bacterial Toxins
Protease domains within toxins typically act as the primary effector domain within target cells. By contrast, the primary function of the cysteine protease domain (CPD) in Multifunctional Autoprocessing RTX-like (MARTX) and Clostridium sp. glucosylating toxin families is to proteolytically cleave th...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2010-05-01
|
Series: | Toxins |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6651/2/5/963/ |
id |
doaj-06ccf668a3c140a9a8554726f3ab4985 |
---|---|
record_format |
Article |
spelling |
doaj-06ccf668a3c140a9a8554726f3ab49852020-11-25T00:58:21ZengMDPI AGToxins2072-66512010-05-012596397710.3390/toxins2050963Autoproteolytic Activation of Bacterial ToxinsAimee ShenProtease domains within toxins typically act as the primary effector domain within target cells. By contrast, the primary function of the cysteine protease domain (CPD) in Multifunctional Autoprocessing RTX-like (MARTX) and Clostridium sp. glucosylating toxin families is to proteolytically cleave the toxin and release its cognate effector domains. The CPD becomes activated upon binding to the eukaryotic-specific small molecule, inositol hexakisphosphate (InsP6), which is found abundantly in the eukaryotic cytosol. This property allows the CPD to spatially and temporally regulate toxin activation, making it a prime candidate for developing anti-toxin therapeutics. In this review, we summarize recent findings related to defining the regulation of toxin function by the CPD and the development of inhibitors to prevent CPD-mediated activation of bacterial toxins. http://www.mdpi.com/2072-6651/2/5/963/cysteine protease domain (CPD)MARTX toxinglucosylating toxin (GT)inositol hexakisphosphate (InsP6)glucosyltransferase (Glc)structure activity relationship (SAR) |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Aimee Shen |
spellingShingle |
Aimee Shen Autoproteolytic Activation of Bacterial Toxins Toxins cysteine protease domain (CPD) MARTX toxin glucosylating toxin (GT) inositol hexakisphosphate (InsP6) glucosyltransferase (Glc) structure activity relationship (SAR) |
author_facet |
Aimee Shen |
author_sort |
Aimee Shen |
title |
Autoproteolytic Activation of Bacterial Toxins |
title_short |
Autoproteolytic Activation of Bacterial Toxins |
title_full |
Autoproteolytic Activation of Bacterial Toxins |
title_fullStr |
Autoproteolytic Activation of Bacterial Toxins |
title_full_unstemmed |
Autoproteolytic Activation of Bacterial Toxins |
title_sort |
autoproteolytic activation of bacterial toxins |
publisher |
MDPI AG |
series |
Toxins |
issn |
2072-6651 |
publishDate |
2010-05-01 |
description |
Protease domains within toxins typically act as the primary effector domain within target cells. By contrast, the primary function of the cysteine protease domain (CPD) in Multifunctional Autoprocessing RTX-like (MARTX) and Clostridium sp. glucosylating toxin families is to proteolytically cleave the toxin and release its cognate effector domains. The CPD becomes activated upon binding to the eukaryotic-specific small molecule, inositol hexakisphosphate (InsP6), which is found abundantly in the eukaryotic cytosol. This property allows the CPD to spatially and temporally regulate toxin activation, making it a prime candidate for developing anti-toxin therapeutics. In this review, we summarize recent findings related to defining the regulation of toxin function by the CPD and the development of inhibitors to prevent CPD-mediated activation of bacterial toxins. |
topic |
cysteine protease domain (CPD) MARTX toxin glucosylating toxin (GT) inositol hexakisphosphate (InsP6) glucosyltransferase (Glc) structure activity relationship (SAR) |
url |
http://www.mdpi.com/2072-6651/2/5/963/ |
work_keys_str_mv |
AT aimeeshen autoproteolyticactivationofbacterialtoxins |
_version_ |
1725220529419321344 |